227 related articles for article (PubMed ID: 24585883)
1. Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase.
Donaldson TM; Cassera MB; Ho MC; Zhan C; Merino EF; Evans GB; Tyler PC; Almo SC; Schramm VL; Kim K
Eukaryot Cell; 2014 May; 13(5):572-9. PubMed ID: 24585883
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii purine nucleoside phosphorylase biochemical characterization, inhibitor profiles, and comparison with the Plasmodium falciparum ortholog.
Chaudhary K; Ting LM; Kim K; Roos DS
J Biol Chem; 2006 Sep; 281(35):25652-8. PubMed ID: 16829527
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function.
Shi W; Ting LM; Kicska GA; Lewandowicz A; Tyler PC; Evans GB; Furneaux RH; Kim K; Almo SC; Schramm VL
J Biol Chem; 2004 Apr; 279(18):18103-6. PubMed ID: 14982926
[TBL] [Abstract][Full Text] [Related]
4. Atomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase.
Kicska GA; Tyler PC; Evans GB; Furneaux RH; Shi W; Fedorov A; Lewandowicz A; Cahill SM; Almo SC; Schramm VL
Biochemistry; 2002 Dec; 41(49):14489-98. PubMed ID: 12463747
[TBL] [Abstract][Full Text] [Related]
5. L-Enantiomers of transition state analogue inhibitors bound to human purine nucleoside phosphorylase.
Rinaldo-Matthis A; Murkin AS; Ramagopal UA; Clinch K; Mee SP; Evans GB; Tyler PC; Furneaux RH; Almo SC; Schramm VL
J Am Chem Soc; 2008 Jan; 130(3):842-4. PubMed ID: 18154341
[TBL] [Abstract][Full Text] [Related]
6. Energetic mapping of transition state analogue interactions with human and Plasmodium falciparum purine nucleoside phosphorylases.
Lewandowicz A; Ringia EA; Ting LM; Kim K; Tyler PC; Evans GB; Zubkova OV; Mee S; Painter GF; Lenz DH; Furneaux RH; Schramm VL
J Biol Chem; 2005 Aug; 280(34):30320-8. PubMed ID: 15961383
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of the 5'-methylthioinosine specificity of Plasmodium purine nucleoside phosphorylase.
Donaldson TM; Ting LM; Zhan C; Shi W; Zheng R; Almo SC; Kim K
PLoS One; 2014; 9(1):e84384. PubMed ID: 24416224
[TBL] [Abstract][Full Text] [Related]
8. Purine nucleoside phosphorylase from Mycobacterium tuberculosis. Analysis of inhibition by a transition-state analogue and dissection by parts.
Basso LA; Santos DS; Shi W; Furneaux RH; Tyler PC; Schramm VL; Blanchard JS
Biochemistry; 2001 Jul; 40(28):8196-203. PubMed ID: 11444965
[TBL] [Abstract][Full Text] [Related]
9. Picomolar transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase and X-ray structure with MT-immucillin-A.
Singh V; Shi W; Evans GB; Tyler PC; Furneaux RH; Almo SC; Schramm VL
Biochemistry; 2004 Jan; 43(1):9-18. PubMed ID: 14705926
[TBL] [Abstract][Full Text] [Related]
10. Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase.
Kicska GA; Tyler PC; Evans GB; Furneaux RH; Schramm VL; Kim K
J Biol Chem; 2002 Feb; 277(5):3226-31. PubMed ID: 11706018
[TBL] [Abstract][Full Text] [Related]
11. Over-the-barrier transition state analogues and crystal structure with Mycobacterium tuberculosis purine nucleoside phosphorylase.
Lewandowicz A; Shi W; Evans GB; Tyler PC; Furneaux RH; Basso LA; Santos DS; Almo SC; Schramm VL
Biochemistry; 2003 May; 42(20):6057-66. PubMed ID: 12755607
[TBL] [Abstract][Full Text] [Related]
12. Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis.
Fedorov A; Shi W; Kicska G; Fedorov E; Tyler PC; Furneaux RH; Hanson JC; Gainsford GJ; Larese JZ; Schramm VL; Almo SC
Biochemistry; 2001 Jan; 40(4):853-60. PubMed ID: 11170405
[TBL] [Abstract][Full Text] [Related]
13. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
Miles RW; Tyler PC; Furneaux RH; Bagdassarian CK; Schramm VL
Biochemistry; 1998 Jun; 37(24):8615-21. PubMed ID: 9628722
[TBL] [Abstract][Full Text] [Related]
14. Transition state analogue inhibitors of purine nucleoside phosphorylase from Plasmodium falciparum.
Kicska GA; Tyler PC; Evans GB; Furneaux RH; Kim K; Schramm VL
J Biol Chem; 2002 Feb; 277(5):3219-25. PubMed ID: 11707439
[TBL] [Abstract][Full Text] [Related]
15. Four generations of transition-state analogues for human purine nucleoside phosphorylase.
Ho MC; Shi W; Rinaldo-Matthis A; Tyler PC; Evans GB; Clinch K; Almo SC; Schramm VL
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):4805-12. PubMed ID: 20212140
[TBL] [Abstract][Full Text] [Related]
16. Immucillins in custom catalytic-site cavities.
Murkin AS; Clinch K; Mason JM; Tyler PC; Schramm VL
Bioorg Med Chem Lett; 2008 Nov; 18(22):5900-3. PubMed ID: 18778937
[TBL] [Abstract][Full Text] [Related]
17. Structures of purine nucleoside phosphorylase from Mycobacterium tuberculosis in complexes with immucillin-H and its pieces.
Shi W; Basso LA; Santos DS; Tyler PC; Furneaux RH; Blanchard JS; Almo SC; Schramm VL
Biochemistry; 2001 Jul; 40(28):8204-15. PubMed ID: 11444966
[TBL] [Abstract][Full Text] [Related]
18. Ionic states of substrates and transition state analogues at the catalytic sites of N-ribosyltransferases.
Sauve AA; Cahill SM; Zech SG; Basso LA; Lewandowicz A; Santos DS; Grubmeyer C; Evans GB; Furneaux RH; Tyler PC; McDermott A; Girvin ME; Schramm VL
Biochemistry; 2003 May; 42(19):5694-705. PubMed ID: 12741826
[TBL] [Abstract][Full Text] [Related]
19. Conformational states of human purine nucleoside phosphorylase at rest, at work, and with transition state analogues.
Edwards AA; Tipton JD; Brenowitz MD; Emmett MR; Marshall AG; Evans GB; Tyler PC; Schramm VL
Biochemistry; 2010 Mar; 49(9):2058-67. PubMed ID: 20108972
[TBL] [Abstract][Full Text] [Related]
20. Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.
Evans GB; Furneaux RH; Lewandowicz A; Schramm VL; Tyler PC
J Med Chem; 2003 Jul; 46(15):3412-23. PubMed ID: 12852771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
